Cue Biopharma Inc at JMP Securities Life Sciences Conference Transcript
So good afternoon, everyone. It's my pleasure to welcome Cue Biopharma. Cue is one of our most interesting companies working in the immunotherapy space, really trying to harness the power of IL-2.
And so here to tell us about the company is CEO, Dan Passeri; CSO, Anish. And go ahead and give us a little bit of an update, obviously, on the company. And then we'll jump into some questions.
Okay. Thanks, Ren. Really appreciate it and welcome, everyone. I also want to thank JMP Securities for giving us an opportunity to present. We'll have few forward-looking statements in the presentation.
So as was stated, our overall vision is to basically deploy in the first case, IL-2. And it's harnessing what we call nature's cues. That's where the company's name comes from.
What we mean by that is the signals that nature has evolved and deploys to modulate the immune system in a highly selective relevant manner. We've basically taken an approach to engineer
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
